Jay R. Venkatesan
2022
In 2022, Jay R. Venkatesan earned a total compensation of $1.5M as former Chief Executive Officer, President, and Chairman of the Angion Board at Elicio Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $11,876 |
|---|---|
| Option Awards | $898,973 |
| Salary | $608,000 |
| Total | $1,518,849 |
Venkatesan received $899K in option awards, accounting for 59% of the total pay in 2022.
Venkatesan also received $11.9K in non-equity incentive plan and $608K in salary.
Rankings
In 2022, Jay R. Venkatesan's compensation ranked 2,188th out of 5,625 executives tracked by ExecPay. In other words, Venkatesan earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,188 out of 5,625 | 61st |
Division Manufacturing | 1,177 out of 3,053 | 61st |
Major group Chemicals And Allied Products | 504 out of 1,380 | 64th |
Industry group Drugs | 464 out of 1,281 | 64th |
Industry Pharmaceutical Preparations | 337 out of 927 | 64th |
Source: SEC filing on September 27, 2024.
Venkatesan's colleagues
We found three more compensation records of executives who worked with Jay R. Venkatesan at Elicio Therapeutics in 2022.